Aetiology and treatment of sleep disturbances during perimenopause and postmenopause

Citation
P. Polo-kantola et al., Aetiology and treatment of sleep disturbances during perimenopause and postmenopause, CNS DRUGS, 15(6), 2001, pp. 445-452
Citations number
55
Categorie Soggetti
Pharmacology,"Neurosciences & Behavoir
Journal title
CNS DRUGS
ISSN journal
11727047 → ACNP
Volume
15
Issue
6
Year of publication
2001
Pages
445 - 452
Database
ISI
SICI code
1172-7047(2001)15:6<445:AATOSD>2.0.ZU;2-J
Abstract
The sudden and predictable cessation of ovarian endocrinological function a t menopause results in a marked decrease of endogenous estrogen and progest ogen secretion. In addition to cessation of menstruation, a wide range of b iological functions, including sleep, are affected. Sleep disturbances are more common in women than in men and their incidence increases with age. Th ere are 2 distinct mechanisms by which menopause is known to affect sleep q uality. One is menopausal insomnia, which can be considered as part of the symptomatology of the climacterium. Another is sleep-disordered breathing, where impairment of sleep quality is secondary to sleep apnoea or partial u pper airway obstruction during sleep. The former is effectively controlled with conventional estrogen replacement therapy, whereas the latter could po tentially be improved with progestogens. Many age-related conditions withou t a direct link with the menopause should also be considered when treating postmenopausal sleep disorders.